首页> 外文期刊>International wound journal. >Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastase
【24h】

Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of matrix metalloproteinases and neutrophil elastase

机译:羊前胃基质生物材料是基质金属蛋白酶和中性粒细胞弹性蛋白酶的广谱抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Proteases play a critical role in the ordered remodelling of extracellular matrix (ECM) components during wound healing and tissue regeneration. However, the usually ordered proteolysis is compromised in chronic wounds due to over-expression and high concentrations of matrix metalloproteinase's (MMPs) and neutrophil elastase (NE). Ovine forestomach matrix (OFM) is a decellularised extracellular matrix-based biomaterial developed for tissue regeneration applications, including the treatment of chronic wounds, and is a heterogeneous mixture of ECM proteins and proteoglycans that retains the native structural and functional characteristics of tissue ECM. Given the diverse molecular species present in OFM, we hypothesised that OFM may contain components or fragments that inhibit MMP and NE activity. An extract of OFM was shown to be a potent inhibitor of a range of tissue MMPs (IC(50)s = 23 +/- 5 to 115 +/- 14 mu g/ml) and NE (IC50 = 157 +/- 37 mu g/ml), and was more potent than extracts prepared from a known protease modulating wound dressing. The broad spectrum activity of OFM against different classes of MMPs (i.e. collagenases, gelatinases and stromelysins) may provide a clinical advantage by more effectively addressing the protease imbalance seen in chronic wounds.
机译:蛋白酶在伤口愈合和组织再生过程中在细胞外基质(ECM)成分的有序重塑中起关键作用。然而,由于过度表达和高浓度的基质金属蛋白酶(MMP)和中性粒细胞弹性蛋白酶(NE),在慢性伤口中通常有序的蛋白水解受到损害。羊前胃基质(OFM)是一种基于脱细胞的细胞外基质的生物材料,专为组织再生应用开发,包括治疗慢性伤口,是ECM蛋白和蛋白聚糖的异质混合物,保留了组织ECM的天然结构和功能特征。鉴于OFM中存在多种分子,我们假设OFM可能含有抑制MMP和NE活性的成分或片段。 OFM提取物被证明是一系列组织MMP(IC(50)s = 23 +/- 5至115 +/- 14μg/ ml)和NE(IC50 = 157 +/- 37)的有效抑制剂(μg/ ml),并且比从已知的蛋白酶调节伤口敷料制备的提取物更有效。 OFM针对不同类别的MMP(即胶原酶,明胶酶和溶血素溶素)的广谱活性可通过更有效地解决慢性伤口中可见的蛋白酶失衡而提供临床优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号